Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

0.9292
Delayed Data
As of 9:52am ET
 +0.0218 / +2.40%
Today’s Change
0.26
Today|||52-Week Range
2.40
-30.14%
Year-to-Date
No recent news for Navidea Biopharmaceuticals Inc.

Today’s Trading

Previous close0.91
Today’s open0.91
Day’s range0.90 - 0.94
Volume117,910
Average volume (3 months)2,029,125
Market cap$141.3M
Dividend yield--
Data as of 9:52am ET, 09/28/2016

Growth & Valuation

Earnings growth (last year)+25.00%
Earnings growth (this year)+55.56%
Earnings growth (next 5 years)--
Revenue growth (last year)+111.15%
P/E ratioNM
Price/Sales15.18
Price/Book--

Competitors

 Today’s
change
Today’s
% change
XENEXenon Pharmaceutical...+0.07+0.86%
KURAKura Oncology Inc+0.03+0.45%
ECYTEndocyte Inc+0.03+0.91%
FBIOFortress Biotech Inc+0.03+1.01%
Data as of 10:08am ET, 09/28/2016

Financials

Next reporting dateNovember 2, 2016
EPS forecast (this quarter)-$0.02
Annual revenue (last year)$13.2M
Annual profit (last year)-$27.6M
Net profit margin-213.76%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mike M. Goldberg
Chief Operating &
Financial Officer
Jed Andrew Latkin
Corporate headquarters
Dublin, Ohio

Forecasts

Search for Jobs